• The global general anesthetic drug market is set to soar from $5.2B in 2025 to over $6.2B by 2035! Aging populations, rising surgeries, tech advancements & better healthcare in emerging nations are fueling the demand for safer, faster, and more effective anesthetics.

    Click Here for More Information:- https://www.futuremarketinsights.com/reports/general-anesthesia-drugs-market

    Get Sample Report: - https://www.futuremarketinsights.com/reports/sample/rep-gb-388

    #Healthcare #Pharma #Anesthesia #MedicalTech #SurgeryInnovation
    💉 The global general anesthetic drug market is set to soar from $5.2B in 2025 to over $6.2B by 2035! 🌍🚀 Aging populations, rising surgeries, tech advancements & better healthcare in emerging nations are fueling the demand for safer, faster, and more effective anesthetics. Click Here for More Information:- https://www.futuremarketinsights.com/reports/general-anesthesia-drugs-market Get Sample Report: - https://www.futuremarketinsights.com/reports/sample/rep-gb-388 #Healthcare #Pharma #Anesthesia #MedicalTech #SurgeryInnovation
    WWW.FUTUREMARKETINSIGHTS.COM
    General Anesthesia Drugs Market Size, Trends & Forecast 2035
    Learn how evolving surgical procedures and anesthesia innovations are optimizing patient care and recovery.
    0 Comentários 0 Compartilhamentos 174 Visualizações
  • The High Content Screening (HCS) market is set to grow from $1.9B in 2025 to $3.1B by 2035! Powered by AI, 3D cell imaging & automation, HCS is revolutionizing drug discovery across oncology, neurology & more. Top players like Thermo Fisher & PerkinElmer are leading the charge!

    Click Here for More Information:- https://www.futuremarketinsights.com/reports/high-content-screening-market

    Get Sample Report: - https://www.futuremarketinsights.com/reports/sample/rep-gb-426


    #Biotech #DrugDiscovery #AI #HCS #PharmaInnovation
    🚀 The High Content Screening (HCS) market is set to grow from $1.9B in 2025 to $3.1B by 2035! 💡 Powered by AI, 3D cell imaging & automation, HCS is revolutionizing drug discovery across oncology, neurology & more. Top players like Thermo Fisher & PerkinElmer are leading the charge! Click Here for More Information:- https://www.futuremarketinsights.com/reports/high-content-screening-market Get Sample Report: - https://www.futuremarketinsights.com/reports/sample/rep-gb-426 #Biotech #DrugDiscovery #AI #HCS #PharmaInnovation
    WWW.FUTUREMARKETINSIGHTS.COM
    High Content Screening Market Size & Outlook 2025 to 2035
    The high-content screening market is projected to reach USD 3.1 billion by 2035, up from USD 1.9 billion in 2025, at a 5.2% CAGR.
    0 Comentários 0 Compartilhamentos 157 Visualizações
  • Enhancing Efficiency with Non-Ferrous Heat Exchangers – A Smart Choice by Gas Processing

    In industries where corrosion resistance, thermal efficiency, and longevity are critical, Non-Ferrous Heat Exchangers have become the preferred solution. Whether it's chemical processing, power generation, or HVAC systems, choosing the right heat exchanger material can make a massive difference in performance and maintenance costs.
    At Gas Processing, we specialize in advanced, custom-engineered non-ferrous heat exchangers that offer superior performance and reliability across a wide range of industrial applications.
    What Are Non-Ferrous Heat Exchangers?
    Non-ferrous heat exchangers are built using metals that do not contain significant amounts of iron. Common non-ferrous materials include:
    Copper


    Aluminum


    Brass


    Titanium


    Nickel Alloys


    These materials are chosen for their excellent corrosion resistance, lightweight properties, and superior thermal conductivity compared to ferrous metals like steel.
    Key Benefits of Non-Ferrous Heat Exchangers
    1. Corrosion Resistance
    In industries dealing with aggressive fluids, saltwater, or acidic environments, corrosion is a major challenge. Non-ferrous metals like copper-nickel and titanium resist corrosion far better than carbon steel, significantly extending the life of the heat exchanger.
    2. Superior Thermal Conductivity
    Materials like copper and aluminum are excellent conductors of heat, allowing faster and more efficient heat transfer. This leads to better energy efficiency and smaller unit sizes.
    3. Lightweight and Compact
    Non-ferrous heat exchangers are often lighter, making them easier to install and maintain. Their compact design also allows for greater space savings in tight installations.
    4. Low Maintenance Requirements
    Because of their resistance to scale, corrosion, and fouling, non-ferrous exchangers require less frequent cleaning and inspection—reducing operational downtime.
    Applications of Non-Ferrous Heat Exchangers
    Non-ferrous heat exchangers are used in various industries, including:
    Chemical & Petrochemical Plants


    Marine and Offshore Applications


    Power Generation


    Pharmaceuticals


    Food & Beverage Processing


    HVAC & Refrigeration Systems


    Their versatility and robustness make them suitable for both high-pressure and high-temperature environments.
    Why Choose Gas Processing?
    At Gas Processing, we combine decades of engineering expertise with state-of-the-art manufacturing technology to deliver non-ferrous heat exchangers that are:
    Custom-designed to meet your specific process needs


    Manufactured to international standards (ASME, TEMA, ISO)


    Available in various configurations: shell & tube, plate, finned, and more


    Rigorously tested for quality, pressure, and performance


    Our team works closely with clients from concept to commissioning, ensuring a seamless integration into your process system.
    Conclusion
    Whether you're upgrading an existing system or designing a new plant, choosing a non-ferrous heat exchanger can dramatically improve your system's durability, efficiency, and reliability. With Gas Processing, you're not just buying a product—you're investing in performance, precision, and peace of mind.
    Ready to elevate your heat transfer solutions? Contact Gas Processing today to discuss your non-ferrous heat exchanger requirements.
    Visit us https://gasprocessing.in/processing-equipment/

    Non-Ferrous Heat exchanger, Heat Exchanger Manufacturer in India
    Enhancing Efficiency with Non-Ferrous Heat Exchangers – A Smart Choice by Gas Processing In industries where corrosion resistance, thermal efficiency, and longevity are critical, Non-Ferrous Heat Exchangers have become the preferred solution. Whether it's chemical processing, power generation, or HVAC systems, choosing the right heat exchanger material can make a massive difference in performance and maintenance costs. At Gas Processing, we specialize in advanced, custom-engineered non-ferrous heat exchangers that offer superior performance and reliability across a wide range of industrial applications. What Are Non-Ferrous Heat Exchangers? Non-ferrous heat exchangers are built using metals that do not contain significant amounts of iron. Common non-ferrous materials include: Copper Aluminum Brass Titanium Nickel Alloys These materials are chosen for their excellent corrosion resistance, lightweight properties, and superior thermal conductivity compared to ferrous metals like steel. Key Benefits of Non-Ferrous Heat Exchangers 1. Corrosion Resistance In industries dealing with aggressive fluids, saltwater, or acidic environments, corrosion is a major challenge. Non-ferrous metals like copper-nickel and titanium resist corrosion far better than carbon steel, significantly extending the life of the heat exchanger. 2. Superior Thermal Conductivity Materials like copper and aluminum are excellent conductors of heat, allowing faster and more efficient heat transfer. This leads to better energy efficiency and smaller unit sizes. 3. Lightweight and Compact Non-ferrous heat exchangers are often lighter, making them easier to install and maintain. Their compact design also allows for greater space savings in tight installations. 4. Low Maintenance Requirements Because of their resistance to scale, corrosion, and fouling, non-ferrous exchangers require less frequent cleaning and inspection—reducing operational downtime. Applications of Non-Ferrous Heat Exchangers Non-ferrous heat exchangers are used in various industries, including: Chemical & Petrochemical Plants Marine and Offshore Applications Power Generation Pharmaceuticals Food & Beverage Processing HVAC & Refrigeration Systems Their versatility and robustness make them suitable for both high-pressure and high-temperature environments. Why Choose Gas Processing? At Gas Processing, we combine decades of engineering expertise with state-of-the-art manufacturing technology to deliver non-ferrous heat exchangers that are: Custom-designed to meet your specific process needs Manufactured to international standards (ASME, TEMA, ISO) Available in various configurations: shell & tube, plate, finned, and more Rigorously tested for quality, pressure, and performance Our team works closely with clients from concept to commissioning, ensuring a seamless integration into your process system. Conclusion Whether you're upgrading an existing system or designing a new plant, choosing a non-ferrous heat exchanger can dramatically improve your system's durability, efficiency, and reliability. With Gas Processing, you're not just buying a product—you're investing in performance, precision, and peace of mind. 📞 Ready to elevate your heat transfer solutions? Contact Gas Processing today to discuss your non-ferrous heat exchanger requirements. Visit us https://gasprocessing.in/processing-equipment/ Non-Ferrous Heat exchanger, Heat Exchanger Manufacturer in India
    GASPROCESSING.IN
    Certified EIL registered manufacturer of Process Equipment India
    Certified process equipment by EIL-registered experts. GPE manufactures U Stamp pressure vessels and non-ferrous heat exchangers in India.
    0 Comentários 0 Compartilhamentos 806 Visualizações
  • Cosa c'è dietro le virostar del Covid?

    Crisanti, Bassetti, Burioni & co. - hanno ricevuto milioni da Big Pharma, Pfizer e fondazioni private come quella di Bill Gates.

    ⚡️ Dal 2016 al 2022: oltre 1 miliardo di euro.

    Coincidenze o conflitto d’interessi?

    ALF_404

    Fonte Telegram La Voce Libera
    🚨 Cosa c'è dietro le virostar del Covid? 🤡 Crisanti, Bassetti, Burioni & co. - hanno ricevuto milioni da Big Pharma, Pfizer e fondazioni private come quella di Bill Gates. ⚡️ Dal 2016 al 2022: oltre 1 miliardo di euro. 🔺 Coincidenze o conflitto d’interessi? ✍️ ALF_404 Fonte Telegram👉 La Voce Libera
    Angry
    2
    0 Comentários 0 Compartilhamentos 489 Visualizações 9
  • The Alzheimer's Therapeutics Market is evolving fast! With disease-modifying therapies, AI-powered R&D, and strategic partnerships, major players like Eisai, Novartis & AbbVie lead the charge. Mid-tier firms & rising biotech stars are investing in next-gen treatments to slow cognitive decline. Market to hit $4.28B soon—innovation is accelerating!

    Get Sample PDF:- https://www.futuremarketinsights.com/reports/sample/rep-gb-20808

    Purchase Here to Get Full Report Access:- https://www.futuremarketinsights.com/checkout/20808

    #Alzheimers #Biotech #PharmaNews #Innovation #DrugDiscovery
    🧠 The Alzheimer's Therapeutics Market is evolving fast! 🚀 With disease-modifying therapies, AI-powered R&D, and strategic partnerships, major players like Eisai, Novartis & AbbVie lead the charge. 🧬 Mid-tier firms & rising biotech stars are investing in next-gen treatments to slow cognitive decline. 🌍 Market to hit $4.28B soon—innovation is accelerating! Get Sample PDF:- https://www.futuremarketinsights.com/reports/sample/rep-gb-20808 Purchase Here to Get Full Report Access:- https://www.futuremarketinsights.com/checkout/20808 💊 #Alzheimers #Biotech #PharmaNews #Innovation #DrugDiscovery
    Alzheimer's Therapeutics Market Share Analysis - Sample | Future Market Insights
    Request a Free Sample for Alzheimer's Therapeutics Market Share Analysis
    0 Comentários 0 Compartilhamentos 928 Visualizações
  • DA VEDERE ASSOLUTAMENTE fino ALLA FINE! GLI ORRORI della SPERIMENTAZONE dai VACCINI COVID-19. I DATI della SPERIMENTAZIONE sono STATI TENUTI NASCOSTI esclusivamente per FARE PROFITTI. MASSIMA DIFFUSIONE!
    DA INOLTRARE a Bassetti, Burioni, Pregliasco, Capua e a tutte le VIROSTAR da STRAPAZZO con CONFLITTI di INTERESSI con Le BIG PHARMA, grandi come una casa!
    E ADESSO ci VOGLIONO RIPROVARE con i vaccini a mRNA AUTOREPLICANTE!
    ASSASSINI!

    DUB/ITA - Inside the Vaccine Trials - Lived Experiences
    Alla scoperta delle sperimentazioni sui vaccini - Esperienze vissute

    ⏺Questo docu-film offre uno sguardo intimo sulla vita dei volontari che hanno partecipato alla sperimentazione del vaccino.

    ⏺Queste persone si sono presentate con speranza e fiducia, solo per andare incontro a gravi e durature complicazioni di salute.

    Ora, dovendo districarsi in un sistema che offre scarso sostegno, le loro storie mettono in luce una preoccupazione più ampia: i danni post-vaccinali sono spesso ignorati e le voci vengono soffocate da una censura intensa.

    https://rumble.com/v6w623s-dubita-docufilm-alla-scoperta-delle-sperimentazioni-sui-vaccini-esperienze-.html
    DA VEDERE ASSOLUTAMENTE fino ALLA FINE! GLI ORRORI della SPERIMENTAZONE dai VACCINI COVID-19. I DATI della SPERIMENTAZIONE sono STATI TENUTI NASCOSTI esclusivamente per FARE PROFITTI. MASSIMA DIFFUSIONE! DA INOLTRARE a Bassetti, Burioni, Pregliasco, Capua e a tutte le VIROSTAR da STRAPAZZO con CONFLITTI di INTERESSI con Le BIG PHARMA, grandi come una casa! E ADESSO ci VOGLIONO RIPROVARE con i vaccini a mRNA AUTOREPLICANTE! ASSASSINI! DUB/ITA - Inside the Vaccine Trials - Lived Experiences Alla scoperta delle sperimentazioni sui vaccini - Esperienze vissute ⏺Questo docu-film offre uno sguardo intimo sulla vita dei volontari che hanno partecipato alla sperimentazione del vaccino. ⏺Queste persone si sono presentate con speranza e fiducia, solo per andare incontro a gravi e durature complicazioni di salute. ✅Ora, dovendo districarsi in un sistema che offre scarso sostegno, le loro storie mettono in luce una preoccupazione più ampia: i danni post-vaccinali sono spesso ignorati e le voci vengono soffocate da una censura intensa. https://rumble.com/v6w623s-dubita-docufilm-alla-scoperta-delle-sperimentazioni-sui-vaccini-esperienze-.html
    Angry
    Like
    4
    0 Comentários 0 Compartilhamentos 3K Visualizações
  • M&A & Investment Trends in North America Tert‑Butanol 2028

    Get a sample PDF of the report – https://www.businessmarketinsights.com/sample/TIPRE00025800?utm_source=Blog&utm_medium=10640

    The tert butanol market in North America is expected to grow from US$ 1,208.95 million in 2021 to US$ 1,424.75 million by 2028; it is estimated to grow at a CAGR of 2.4% from 2021 to 2028.

    Get Full Report: https://www.businessmarketinsights.com/reports/north-america-tert-butanol-market

    The US, Canada, and Mexico are major economies in North America. The tert butanol market in North America has significant opportunities due to the high demand for tert butanol form various end-use industries, such as pharmaceuticals, and paint and coatings. Due to growing building and construction activities in North America, the demand for tert butanol is increasing from the downstream solvent and paint industries. There is a growing use of tert butanol as a chemical intermediate for a range of products. Dehydrated tert butanol in the form of high purity isobutylene has wide applications in fuel additives and lubricants. Additionally, the US has strong automotive industry that propels the demand for high purity isobutylene, which has the tyres and lubricants sectors as end markets.
    M&A & Investment Trends in North America Tert‑Butanol 2028 Get a sample PDF of the report – https://www.businessmarketinsights.com/sample/TIPRE00025800?utm_source=Blog&utm_medium=10640 The tert butanol market in North America is expected to grow from US$ 1,208.95 million in 2021 to US$ 1,424.75 million by 2028; it is estimated to grow at a CAGR of 2.4% from 2021 to 2028. Get Full Report: https://www.businessmarketinsights.com/reports/north-america-tert-butanol-market The US, Canada, and Mexico are major economies in North America. The tert butanol market in North America has significant opportunities due to the high demand for tert butanol form various end-use industries, such as pharmaceuticals, and paint and coatings. Due to growing building and construction activities in North America, the demand for tert butanol is increasing from the downstream solvent and paint industries. There is a growing use of tert butanol as a chemical intermediate for a range of products. Dehydrated tert butanol in the form of high purity isobutylene has wide applications in fuel additives and lubricants. Additionally, the US has strong automotive industry that propels the demand for high purity isobutylene, which has the tyres and lubricants sectors as end markets.
    0 Comentários 0 Compartilhamentos 1K Visualizações
  • Maintaining the Chill: Best Practices in Cold Logistics

    In today’s fast paced global economy, the demand for reliable and efficient transportation of perishable goods has grown tremendously. From fresh produce and dairy to pharmaceuticals and flowers, businesses depend on a seamless supply chain to deliver temperature sensitive products while maintaining their quality and safety.

    For more info visit : https://market.us/report/global-perishable-goods-transportation-market/
    Maintaining the Chill: Best Practices in Cold Logistics In today’s fast paced global economy, the demand for reliable and efficient transportation of perishable goods has grown tremendously. From fresh produce and dairy to pharmaceuticals and flowers, businesses depend on a seamless supply chain to deliver temperature sensitive products while maintaining their quality and safety. For more info visit : https://market.us/report/global-perishable-goods-transportation-market/
    MARKET.US
    Perishable Goods Transportation Market
    Global Perishable Goods Transportation Market size is expected to be Reach USD 35.2 Bn by 2034, from USD 20.4 Bn in 2024, at a CAGR of 5.6%
    0 Comentários 0 Compartilhamentos 501 Visualizações
  • PERCHÉ SI PROSEGUE CON L’APPLICAZIONE DELL’OBBLIGO VACCINALE SE LO STATO È INADEMPIENTE VERSO LA STESSA LEGGE LORENZIN NEL NON AVER MAI ATTUATO IL MONITORAGGIO TRIENNALE SULLO STATO DI SALUTE DEI BAMBINI VACCINATI?

    Il bilanciamento tra diritto individuale e collettivo è decisamente sbilanciato a favore dell’interesse delle multinazionali. Le vaccinazioni obbligatorie, lo abbiamo dimostrato ampiamente nei numerosi approfondimenti che abbiamo fatto in occasione della raccolta firme per il referendum contro l’obbligo vaccinale, sia nel merito che nel metodo, non tutelano la salute individuale e nemmeno quella collettiva, ma fanno molto ingrassare i bilanci delle Big Pharma.

    https://youtu.be/pwkasny7gYI

    https://www.youtube.com/live/BqpLhY6C2PQ?si=1wvFQDUXb0t0rVpK

    Ormai il re è nudo!

    Ve lo dico io perché non fanno i monitoraggi triennali, perché la farmacovigilanza attiva che hanno sperimentato nella regione Puglia ha prodotto risultati allarmanti per il numero degli effetti avversi registrati.

    Studi seri, infatti, potrebbero portare alla dismissione degli obblighi vaccinali e quindi al tracollo del volume di affari dei colossi della farmaceutica. I tagli alla sanità pubblica nell’ambito delle cure e della diagnostica crescono in misura direttamente proporzionale alla crescita della spesa pubblica devoluta ai vaccini o per la popolazione residente o per i paesi sottosviluppati, attraverso il finanziamento di fondazioni come la GAVI alliance di Bill Gates. Il ministro Tajani si è recentemente vantato in un tweet di aver devoluto altri 250 mln di euro del bilancio dello stato alla GAVI ALLIANCE.

    Comunque, questa omissione nell’applicazione della legge Lorenzin da parte dello stato per quanto attiene i monitoraggi triennali può tranquillamente essere usata come fondata motivazione per disattendere la vaccinazione: il consenso viene estorto ai genitori col ricatto senza nessuna informazione documentata e senza garanzie da parte dello stato. Qualora la scuola insistesse per l’inoculo, si può far richiesta scritta all’ASL degli esiti dei monitoraggi previsti dalla legge. In caso di omessa risposta, si può porre in essere il diniego informato e denunciare la condotta omissiva dell’ASL all’istituzione scolastica che rifiuti il bambino con una diffida ad accettare l’iscrizione.

    Vi invito ad approfondire con un avvocato, ma in punta di diritto credo che questa sia la strada da percorrere.

    https://quotidianosociale.it/2025/07/09/obbligo-vaccinale-appeso-a-un-filo-laifa-ammette-la-mancata-revisione-triennale-della-legge-lorenzin-creando-un-pericoloso-vuoto-giuridico/
    PERCHÉ SI PROSEGUE CON L’APPLICAZIONE DELL’OBBLIGO VACCINALE SE LO STATO È INADEMPIENTE VERSO LA STESSA LEGGE LORENZIN NEL NON AVER MAI ATTUATO IL MONITORAGGIO TRIENNALE SULLO STATO DI SALUTE DEI BAMBINI VACCINATI? Il bilanciamento tra diritto individuale e collettivo è decisamente sbilanciato a favore dell’interesse delle multinazionali. Le vaccinazioni obbligatorie, lo abbiamo dimostrato ampiamente nei numerosi approfondimenti che abbiamo fatto in occasione della raccolta firme per il referendum contro l’obbligo vaccinale, sia nel merito che nel metodo, non tutelano la salute individuale e nemmeno quella collettiva, ma fanno molto ingrassare i bilanci delle Big Pharma. https://youtu.be/pwkasny7gYI https://www.youtube.com/live/BqpLhY6C2PQ?si=1wvFQDUXb0t0rVpK Ormai il re è nudo! Ve lo dico io perché non fanno i monitoraggi triennali, perché la farmacovigilanza attiva che hanno sperimentato nella regione Puglia ha prodotto risultati allarmanti per il numero degli effetti avversi registrati. Studi seri, infatti, potrebbero portare alla dismissione degli obblighi vaccinali e quindi al tracollo del volume di affari dei colossi della farmaceutica. I tagli alla sanità pubblica nell’ambito delle cure e della diagnostica crescono in misura direttamente proporzionale alla crescita della spesa pubblica devoluta ai vaccini o per la popolazione residente o per i paesi sottosviluppati, attraverso il finanziamento di fondazioni come la GAVI alliance di Bill Gates. Il ministro Tajani si è recentemente vantato in un tweet di aver devoluto altri 250 mln di euro del bilancio dello stato alla GAVI ALLIANCE. Comunque, questa omissione nell’applicazione della legge Lorenzin da parte dello stato per quanto attiene i monitoraggi triennali può tranquillamente essere usata come fondata motivazione per disattendere la vaccinazione: il consenso viene estorto ai genitori col ricatto senza nessuna informazione documentata e senza garanzie da parte dello stato. Qualora la scuola insistesse per l’inoculo, si può far richiesta scritta all’ASL degli esiti dei monitoraggi previsti dalla legge. In caso di omessa risposta, si può porre in essere il diniego informato e denunciare la condotta omissiva dell’ASL all’istituzione scolastica che rifiuti il bambino con una diffida ad accettare l’iscrizione. Vi invito ad approfondire con un avvocato, ma in punta di diritto credo che questa sia la strada da percorrere. https://quotidianosociale.it/2025/07/09/obbligo-vaccinale-appeso-a-un-filo-laifa-ammette-la-mancata-revisione-triennale-della-legge-lorenzin-creando-un-pericoloso-vuoto-giuridico/
    Like
    1
    0 Comentários 0 Compartilhamentos 2K Visualizações
  • Pharmacogenomics Market Role in Antiplatelet and Coagulation Therapies

    The Global Pharmacogenomics Market was valued at US$ 5.58 Billion in 2024 and is expected to grow at a CAGR of 10.6% from 2024 to 2034. In 2024, North America led the market, achieving over 48.5% share with a revenue of US$ 2.7 Billion.

    Click here for more information: https://market.us/report/pharmacogenomics-market/

    Pharmacogenomics Market Role in Antiplatelet and Coagulation Therapies The Global Pharmacogenomics Market was valued at US$ 5.58 Billion in 2024 and is expected to grow at a CAGR of 10.6% from 2024 to 2034. In 2024, North America led the market, achieving over 48.5% share with a revenue of US$ 2.7 Billion. Click here for more information: https://market.us/report/pharmacogenomics-market/
    MARKET.US
    Pharmacogenomics Market
    The Global Pharmacogenomics Market was valued at US$ 5.58 Billion in 2024 and is expected to grow at a CAGR of 10.6% from 2024 to 2034.
    0 Comentários 0 Compartilhamentos 153 Visualizações
Páginas Impulsionadas